基于基因组的早期检测筛查：胃肠道癌症前瞻性试验及新兴策略的文献综述
Genomic-Based Early Detection Screening: A Literature Review of Prospective Trials and Emerging Strategies for Gastrointestinal Cancers.
作者信息
Tizpa Eemon, Sharzehi Kaveh, Nabavizadeh Nima
机构信息
Radiation Oncology, Washington State University Elson S. Floyd College of Medicine, Spokane, USA.
Gastroenterology and Hepatology, Oregon Health and Science University School of Medicine, Portland, USA.
出版信息
Cureus. 2024 Sep 7;16(9):e68881. doi: 10.7759/cureus.68881. eCollection 2024 Sep.
Abstract
Numerous genomic-based early detection screening tests are being developed. These tests have the potential to revolutionize current single-organ screening paradigms, especially in gastrointestinal cancers. In this review, we underscore the performance of these genomic-based early detection tests based on prospective clinical trials. Moreover, we discuss a professional advancement for gastroenterologists in the diagnostic assessment of individuals who are cancer signal positive.
摘要
许多基于基因组的早期检测筛查测试正在研发中。这些测试有可能彻底改变当前的单器官筛查模式，尤其是在胃肠道癌症方面。在本综述中，我们根据前瞻性临床试验强调了这些基于基因组的早期检测测试的性能。此外，我们还讨论了胃肠病学家在对癌症信号呈阳性的个体进行诊断评估方面的专业进展。
相似文献
1
Genomic-Based Early Detection Screening: A Literature Review of Prospective Trials and Emerging Strategies for Gastrointestinal Cancers.基于基因组的早期检测筛查：胃肠道癌症前瞻性试验及新兴策略的文献综述
Cureus. 2024 Sep 7;16(9):e68881. doi: 10.7759/cureus.68881. eCollection 2024 Sep.
2
Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists.多癌早期检测测试：前瞻性临床研究的早期结果概述及肿瘤学家面临的机遇
JCO Oncol Pract. 2023 Dec;19(12):1111-1115. doi: 10.1200/OP.23.00260. Epub 2023 Oct 18.
3
Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.循环肿瘤DNA等位基因分数：用于多癌早期检测测试以评估癌症临床意义的候选生物信号。
Am J Pathol. 2022 Oct;192(10):1368-1378. doi: 10.1016/j.ajpath.2022.07.007. Epub 2022 Aug 7.
4
Cancer screening with multicancer detection tests: A translational science review.多癌种检测试验进行癌症筛查：转化科学述评。
CA Cancer J Clin. 2024 Jul-Aug;74(4):368-382. doi: 10.3322/caac.21833. Epub 2024 Mar 22.
5
Perspectives of primary care providers regarding multicancer early detection panels.初级保健提供者对多癌种早期检测面板的看法。
Einstein (Sao Paulo). 2024 Aug 23;22:eAO0771. doi: 10.31744/einstein_journal/2024AO0771. eCollection 2024.
6
Assessing the Clinical Utility of Liquid Biopsies Across 5 Potential Indications From Therapy Selection to Population Screening: A Review.评估液体活检在 5 种潜在适应症中的临床应用价值：从治疗选择到人群筛查的综述。
JAMA Intern Med. 2023 Oct 1;183(10):1144-1151. doi: 10.1001/jamainternmed.2023.3603.
7
Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers - current evidence and future directions.循环肿瘤来源DNA在胃肠道癌症管理中的临床应用——当前证据与未来方向
Front Oncol. 2022 Sep 29;12:970242. doi: 10.3389/fonc.2022.970242. eCollection 2022.
8
Multiyear Clinical Outcomes of Cancers Diagnosed Following Detection by a Blood-Based Multicancer Early Detection Test.基于血液的多癌早期检测试验检测出的癌症的多年临床结局
Cancer Prev Res (Phila). 2024 Aug 1;17(8):349-353. doi: 10.1158/1940-6207.CAPR-24-0107.
9
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. 2021, , 2171.多癌早期检测的前景。对庞斯 - 贝尔达等人的评论。循环肿瘤DNA能否支持早期癌症检测的成功筛查测试？圣杯范式。2021年，，2171。 （注：原文中存在一些格式不规范和不完整的地方，可能会影响准确理解。）
Diagnostics (Basel). 2022 May 17;12(5):1243. doi: 10.3390/diagnostics12051243.
10
Assessment of circulating copy number variant detection for cancer screening.用于癌症筛查的循环拷贝数变异检测评估。
PLoS One. 2017 Jul 7;12(7):e0180647. doi: 10.1371/journal.pone.0180647. eCollection 2017.
本文引用的文献
1
Improving Noninvasive Colorectal Cancer Screening.改善非侵入性结直肠癌筛查
N Engl J Med. 2024 Mar 14;390(11):1045-1046. doi: 10.1056/NEJMe2400366.
2
Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.用于结直肠癌筛查的下一代多靶点粪便 DNA 检测。
N Engl J Med. 2024 Mar 14;390(11):984-993. doi: 10.1056/NEJMoa2310336.
3
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
4
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
5
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.首发癌症症状特征：来自 2018 年英国国家癌症诊断审计的证据。
Br J Cancer. 2024 Feb;130(2):297-307. doi: 10.1038/s41416-023-02507-4. Epub 2023 Dec 6.
6
Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists.多癌早期检测测试：前瞻性临床研究的早期结果概述及肿瘤学家面临的机遇
JCO Oncol Pract. 2023 Dec;19(12):1111-1115. doi: 10.1200/OP.23.00260. Epub 2023 Oct 18.
7
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study.基于血液的多种癌症早期检测（PATHFINDER）：一项前瞻性队列研究。
Lancet. 2023 Oct 7;402(10409):1251-1260. doi: 10.1016/S0140-6736(23)01700-2.
8
The aggregate value of cancer screenings in the United States: full potential value and value considering adherence.美国癌症筛查的总价值：充分潜力价值和考虑依从性的价值。
BMC Health Serv Res. 2023 Aug 7;23(1):829. doi: 10.1186/s12913-023-09738-4.
9
Editorial: Reviews in gastrointestinal cancers.社论：胃肠道癌症综述
Front Oncol. 2023 Jul 18;13:1252665. doi: 10.3389/fonc.2023.1252665. eCollection 2023.
10
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.英国和威尔士因癌症检查而转诊的有症状患者的多癌早期检测试验（SYMPLIFY）：一项大规模观察性队列研究
Lancet Oncol. 2023 Jul;24(7):733-743. doi: 10.1016/S1470-2045(23)00277-2. Epub 2023 Jun 20.
Zotero 插件